Fourth quarter earnings have slowed to a trickle after the blowout report from Nvidia (NVDA) capped results for the "Magnificent Seven" tech stocks. With just 4% of S&P 500 companies left to report ...
Fourth quarter earnings have slowed to a trickle after the blowout report from Nvidia (NVDA) capped results for the "Magnificent Seven" tech stocks. With just 4% of S&P 500 companies left to report ...
The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate cancer, according to an industry press release.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results